Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Early Cancer Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, California, USA.
Center for Infertility and Reproductive Surgery, Department of Obstetrics Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
J Tissue Eng Regen Med. 2018 Jan;12(1):e142-e149. doi: 10.1002/term.2439. Epub 2017 Aug 25.
The ability to cryopreserve human oocytes has significant potential for fertility preservation. Current cryopreservation methods still suffer from the use of conventional cryoprotectants, such as dimethyl sulphoxide (DMSO), causing loss of viability and function. Such injuries result from the toxicity and high concentration of cryoprotectants, as well as mechanical damage of cells due to ice crystal formation during the cooling and rewarming processes. Here we report the preservation of human oocytes following vitrification using an innovative bio-inspired cryoprotectant integrated with a minimum volume vitrification approach. The results demonstrate that the recovered human oocytes maintained viability following vitrification and rewarming. Moreover, when this approach was used to vitrify mouse oocytes, the recovered oocytes preserved their viability and function following vitrification and rewarming. This bio-inspired approach substitutes DMSO, a well-known toxic cryoprotectant, with ectoine, a non-toxic naturally occurring solute. The bio-inspired vitrification approach has the potential to improve fertility preservation for women undergoing cancer treatment and endangered mammal species.
冷冻保存人类卵子的能力在生育力保存方面具有重要的潜力。目前的冷冻保存方法仍然受到传统冷冻保护剂的使用的限制,例如二甲亚砜(DMSO),这会导致存活率和功能丧失。这种损伤是由于冷冻保护剂的毒性和高浓度,以及在冷却和复温过程中冰晶形成导致的细胞机械损伤所致。在这里,我们报告了使用创新的仿生冷冻保护剂与最小体积玻璃化方法相结合对人类卵子进行玻璃化保存的情况。结果表明,经玻璃化和复温处理后,回收的人类卵子保持了活力。此外,当将这种方法用于玻璃化处理小鼠卵子时,回收的卵子在玻璃化和复温后保持了活力和功能。这种仿生方法用无毒的天然溶质海藻糖代替了众所周知的有毒冷冻保护剂 DMSO。这种仿生玻璃化方法有可能改善正在接受癌症治疗的女性和濒危哺乳动物物种的生育力保存。